The microbiome drug developer took its total series C funding to more than $62m, adding $16.6m from investors including Symbiosis, JSR and Bristol-Myers Squibb.

Laurel Buckner is heading to venture firm WestRiver Group as a managing director having helped ATN set up its corporate venturing arm.

The retail marketing software provider has now raised $32m altogether, securing funding in a series B round backed by returning investor Sonae IM.

R/GA is exiting drone workflow automation platform Hangar Technology, which has been purchased by AirMap for an undisclosed sum.

Frequency Therapeutics, a regenerative medicine developer advancing MIT and Harvard research, has set the range for an initial public offering that will raise $107m if it floats at the high end.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Facebook has paid a reported $500m to $1bn to acquire neural interface technology developer Ctrl-Labs, which had raised $67m from investors including GV and Alexa Fund.

Curamir Therapeutics, a cancer therapeutics developer exploiting Suny research into microRNA, has made its formal debut with $10m of series A funding.

Regnerative medicine developer Frequency Therapeutics has set the range for an initial public offering that will raise $107m if it floats at the high end.

Strategic partner RXR Realty joined GV to co-lead a series B round that will fund the expansion of Kitchen United’s network of food delivery hubs.